Literature DB >> 4430016

The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

E Cameron, A Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4430016     DOI： 10.1016/0009-2797(74)90019-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN： 0009-2797            Impact factor:   5.192


× No keyword cloud information.
  85 in total

Review 1.  New insights into the physiology and pharmacology of vitamin C.

Authors:  S J Padayatty; M Levine
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

Authors:  L J Hoffer
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

Review 3.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

4.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

5.  Vitamin C and cancer revisited.

Authors:  Balz Frei; Stephen Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

6.  The Xc- inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism.

Authors:  Zijie Zheng; Ganhua Luo; Xinchong Shi; Yali Long; Wanqing Shen; Zhoulei Li; Xiangsong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2019-10-15       Impact factor: 6.730

Review 7.  Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

8.  Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.

Authors:  Peter Bober; Michal Alexovic; Ivan Talian; Zuzana Tomkova; Zuzana Viscorova; Maria Benckova; Igor Andrasina; Rachele Ciccocioppo; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak; Jan Sabo
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

9.  The prospects of vitamin C in cancer therapy.

Authors:  Wang-Jae Lee
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

Review 10.  Vitamin therapy in the absence of obvious deficiency. What is the evidence?

Authors:  L Ovesen
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.